4.7 Article

The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis

Journal

BLOOD
Volume 119, Issue 8, Pages 1946-1955

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-10-384560

Keywords

-

Categories

Funding

  1. National Institutes of Health [T32 HL069768, HL088632, R01 HL43174]
  2. American Heart Association [3490004, 0635228N, 2230268]

Ask authors/readers for more resources

Angiogenesis requires integration of cues from growth factors, extracellular matrix (ECM) proteins, and their receptors in endothelial cells. In the present study, we show that the adaptor protein Shc is required for angiogenesis in zebrafish, mice, and cell-culture models. Shc knockdown zebrafish embryos show defects in intersegmental vessel sprouting in the trunk. Shc flox/flox; Tie2-Cre mice display reduced angiogenesis in the retinal neovascularization model and in response to VEGF in the Matrigel plug assay in vivo. Functional studies reveal a model in which Shc is required for integrin-mediated spreading and migration specifically on fibronectin, as well as endothelial cell survival in response to VEGF. Mechanistically, Shc is required for activation of the Akt pathway downstream of both integrin and VEGF signaling, as well as for integration of signals from these 2 receptors when cells are grown on fibronectin. Therefore, we have identified a unique mechanism in which signals from 2 critical angiogenic signaling axes, integrins and VEGFR-2, converge at Shc to regulate postnatal angiogenesis. (Blood. 2012;119(8):1946-1955)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available